Search results
Showing 136 to 150 of 301 results for breast cancer
In development [GID-TA11400] Expected publication date: TBC
Evidence-based recommendations on dabrafenib (Tafinlar) with trametinib (Mekinist) for resected stage III, BRAF V600 mutation-positive melanoma in adults.
Information for journalists including contact details, FAQS and NICE's stance on key topics.
In development [GID-TA10326] Expected publication date: TBC
Awaiting development [GID-TA11403] Expected publication date: TBC
In development [GID-TA11402] Expected publication date: TBC
Awaiting development [GID-TA11165] Expected publication date: TBC
for neoadjuvant endocrine therapy in postmenopausal women with early breast cancer? Any explanatory notes(if applicable) To find out why...
Awaiting development [GID-TA10896] Expected publication date: TBC
Awaiting development [GID-TA11342] Expected publication date: TBC
Everolimus for advanced renal cell carcinoma after previous treatment (TA432)
Evidence-based recommendations on everolimus (Afinitor) for advanced renal cell carcinoma after previous treatment.
Awaiting development [GID-TA11273] Expected publication date: TBC
Awaiting development [GID-TA11487] Expected publication date: TBC
Early value assessment (EVA) guidance on artificial intelligence technologies to aid contouring for radiotherapy treatment planning in people having external be...
View recommendations for HTE11Show all sections